InventisBio Co., Limited (SHA:688382)
China · Delayed Price · Currency is CNY 43.50
-1.10 (-2.47%)
Last updated: Jul 24, 2025
InventisBio Revenue
InventisBio had revenue of 8.19M CNY in the quarter ending March 31, 2025, a decrease of -4.85%. This brings the company's revenue in the last twelve months to 168.37M, down -13.27% year-over-year. In the year 2024, InventisBio had annual revenue of 168.79M, down -9.02%.
Revenue (ttm)
168.37M
Revenue Growth
-13.27%
P/S Ratio
151.61
Revenue / Employee
910.13K
Employees
185
Market Cap
25.53B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 168.79M | -16.74M | -9.02% |
| Dec 31, 2023 | 185.53M | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | - | - | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jiangsu Hengrui Medicine | 29.19B |
| Shenzhen Mindray Bio-Medical Electronics | 35.59B |
| WuXi AppTec | 39.59B |
| Zhangzhou Pientzehuang Pharmaceutical., | 10.76B |
| Sichuan Biokin Pharmaceutical | 5.82B |
| Aier Eye Hospital Group | 21.81B |
| Shanghai United Imaging Healthcare | 10.43B |
| Yunnan Baiyao Group Co.,Ltd | 40.10B |